Cambridge Nutritional Sciences plc (AIM:CNSL)
London · Delayed Price · Currency is GBP · Price in GBX 2.850
-0.050 (-1.72%)
Oct 10, 2025, 3:44 PM GMT+1
AIM:CNSL Market Cap
AIM:CNSL has a market cap or net worth of 6.78 million as of October 10, 2025. Its market cap has decreased by -22.97% in one year.
Market Cap
6.78M
Enterprise Value
2.26M
Revenue
8.33M
Ranking
n/a
PE Ratio
4.33
Stock Price
2.85
Market Cap Chart
Since December 7, 2007, AIM:CNSL's market cap has increased from 3.12M to 6.78M, an increase of 117.09%. That is a compound annual growth rate of 4.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 6.78M | 3.64% |
| Dec 31, 2024 | 6.54M | 14.71% |
| Dec 29, 2023 | 5.70M | -36.00% |
| Dec 30, 2022 | 8.91M | -82.10% |
| Dec 31, 2021 | 49.78M | -57.11% |
| Dec 31, 2020 | 116.07M | 436.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 198.58B |
| GSK plc | 65.20B |
| Haleon | 30.29B |
| Smith & Nephew | 11.41B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 2.04B |
| Genus | 1.68B |